Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115057834A reveals a low-pressure two-step hydrogenation process for high-purity 2,5-tetrahydrofuran dimethanol, offering substantial cost reduction and scalable supply chain solutions.
Patent CN110387359B discloses engineered enzymes for efficient statin production, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel tetrapeptide-catalyzed asymmetric Aldol synthesis for high-purity pharmaceutical intermediates. Cost-effective route to pantolactone with superior enantioselectivity.
Patent CN103288743B reveals efficient one-pot benzimidazole synthesis. Reduces cost and environmental impact for pharmaceutical intermediates manufacturing supply chains.
Patent CN111848320A reveals a tetrapeptide-catalyzed asymmetric Aldol route achieving 99% ee for pantolactone precursors, offering a scalable, metal-free solution for reliable pharmaceutical intermediate suppliers.
Patent CN101085990A reveals chemo-enzymatic route for high-purity chiral alcohols. Enables cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN111646936A details a high-yield phase transfer catalysis route for aromatic ether compounds, optimizing Nitroxoline prodrug manufacturing supply chains.
Novel transaminase mutants for chiral amine production. Enhanced stability at 55°C and pH 10. Cost-effective biocatalysis for pharma intermediates.
Patent CN101481665B reveals a green biocatalytic route for 2,2-dimethylcyclopropanecarboxamide, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN108727246B details a metal-free visible light method for indole C3 alkylation using organic dyes, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN111072625A reveals a novel diatomite-catalyzed route for 3,4-methylenedioxyacetophenone, offering significant cost reduction and supply chain reliability for pharma intermediates.
Patent CN116179612A reveals multienzyme coupling for VD3. Enhances purity and load capacity while reducing chemical residues for supply chain stability.
Patent CN107417583B reveals metal-free allyl sulfone synthesis. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Patent CN102382780A reveals a novel Microbacterium oxydans strain for high-purity chiral alcohol production, offering significant cost reduction and supply chain stability for global API manufacturers.
Patent CN108546698A reveals high-activity aspartase mutant for L-aspartic acid. Enables cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN120624390A enables high-purity chiral amine synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN112778218A reveals a green method for quinazolinone derivatives using recyclable chitosan-copper catalyst, offering cost reduction and supply chain reliability.
Novel visible-light copper catalyzed synthesis for high-purity alkynyl phosphate intermediates. Offers mild conditions and scalable production for pharmaceutical supply chains.
Patent CN120098034A reveals a neutral photocatalytic route for 1,2-bisphosphonoethane compounds, offering high purity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN109734646B details a high-yield method for diether diphthalimide using ionic liquids, offering significant cost reduction and purity benefits for PEI monomer manufacturing.